B-cell lymphoblastic lymphoma following intravenous BNT162b2 mRNA booster in a BALB/c mouse: A case report

Unprecedented immunization campaigns have been rolled out worldwide in an attempt to contain the ongoing COVID-19 pandemic. Multiple vaccines were brought to the market, among two utilizing novel messenger ribonucleic acid technology. Despite their undisputed success in decreasing COVID-19-associate...

Descripción completa

Detalles Bibliográficos
Autores principales: Eens, Sander, Van Hecke, Manon, Favere, Kasper, Tousseyn, Thomas, Guns, Pieter-Jan, Roskams, Tania, Heidbuchel, Hein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183601/
https://www.ncbi.nlm.nih.gov/pubmed/37197431
http://dx.doi.org/10.3389/fonc.2023.1158124

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183601/
https://www.ncbi.nlm.nih.gov/pubmed/37197431
http://dx.doi.org/10.3389/fonc.2023.1158124

Ejemplares similares